Anavex Life Sciences Corp. (AVXL)
3.105
-0.14
(-4.17%)
USD |
NASDAQ |
Aug 24, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Total Liabilities (Quarterly) : 7.059M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 7.059M |
| December 31, 2025 | 6.371M |
| September 30, 2025 | 8.946M |
| June 30, 2025 | 11.47M |
| March 31, 2025 | 17.38M |
| December 31, 2024 | 13.13M |
| September 30, 2024 | 15.30M |
| June 30, 2024 | 11.75M |
| March 31, 2024 | 9.558M |
| December 31, 2023 | 12.50M |
| September 30, 2023 | 12.53M |
| June 30, 2023 | 11.06M |
| March 31, 2023 | 14.02M |
| December 31, 2022 | 13.25M |
| September 30, 2022 | 10.21M |
| June 30, 2022 | 9.484M |
| March 31, 2022 | 8.071M |
| December 31, 2021 | 10.53M |
| September 30, 2021 | 10.80M |
| June 30, 2021 | 9.274M |
| March 31, 2021 | 7.764M |
| December 31, 2020 | 8.034M |
| September 30, 2020 | 7.306M |
| June 30, 2020 | 6.949M |
| March 31, 2020 | 6.229M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.464M |
| September 30, 2019 | 5.040M |
| June 30, 2019 | 4.337M |
| March 31, 2019 | 6.371M |
| December 31, 2018 | 4.876M |
| September 30, 2018 | 3.885M |
| June 30, 2018 | 3.209M |
| March 31, 2018 | 3.417M |
| December 31, 2017 | 2.798M |
| September 30, 2017 | 3.584M |
| June 30, 2017 | 1.455M |
| March 31, 2017 | 2.120M |
| December 31, 2016 | 2.195M |
| September 30, 2016 | 3.190M |
| June 30, 2016 | 2.173M |
| March 31, 2016 | 2.432M |
| December 31, 2015 | 2.533M |
| September 30, 2015 | 2.661M |
| June 30, 2015 | 1.410M |
| March 31, 2015 | 1.662M |
| December 31, 2014 | 6.577M |
| September 30, 2014 | 7.161M |
| June 30, 2014 | 1.905M |
| March 31, 2014 | 1.884M |
| December 31, 2013 | 1.821M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | 24.13M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 128.77M |
| Shareholders Equity (Quarterly) | 121.71M |
| Current Ratio | 18.24 |